Category: Drug Safety Alerts
-
Asthma Drug Xolair Is Being Investigated By FDA For Possible Cardiac Problems
Serious Side Effects Include Heart Attacks, Abnormal Heart Rhythms, Heart Failure, And Various Conditions Caused By Blood Clots (Posted by Tom Lamb at DrugInjuryWatch.com) ______________________________________________________________________________ UPDATE: "Xolair Is Associated With Higher Than Expected Reporting…
-
Some Users Of Alli And Xenical Have Developed Serious Liver Injury Including Liver Failure
FDA Early Communication Makes Clear That No Definite Association Between Liver Injury And Orlistat Has Been Established At This Time (Posted by Tom Lamb at DrugInjuryWatch.com) On May 22, 2009 we first reported that…
-
YAZ And Yasmin May Have Higher Risk Of Venous Thrombosis Than Older Birth Control Pills
Recent Studies Find That New Progestin Drospirenone Has 1.7 Times Increased Risk Of Developing Blood Clots Compared To Levonorgestrel (Posted by Tom Lamb at DrugInjuryWatch.com) _________________________________________________________________________________________ UPDATE: "Bayer Affirms Safety Of YAZ / Yasmin…
-
Diabetes Drug Avandia Associated With Liver Injury And Liver Failure, Again
July 2009 Medical Journal Article Follows 2008 Public Citizen's Petition For FDA To Ban Sales Of Avandia In U.S. (Posted by Tom Lamb at DrugInjuryWatch.com) In October 2008 Public Citizen petitioned the FDA to…
-
Yasmin / YAZ Multidistrict Litigation (MDL) Motion Filed Late July 2009
Requests Consolidation Of Federal Court Lawsuits Alleging Yasmin Or YAZ Caused Injury Such As Stroke, Heart Attack, Pulmonary Thrombosis, Deep Vein Thrombosis, And Death (Posted by Tom Lamb at DrugInjuryWatch.com) _____________________________________________________________________ Update: On October 1,…
-
History Of Singulair And Psychiatric Adverse Reactions In Canada: 1997 – January 2009
July 2009 Canadian Adverse Reaction Newsletter Provides Summary Of Reports Made To Health Canada (Posted by Tom Lamb at DrugInjuryWatch.com) Singulair (montelukast) has been marketed in Canada since 1997. In Canada Singulair is indicated…
-
Popular Asthma Medicine Singulair Associated With Psychiatric Disorders In Children
New Medical Journal Article Follows June 2009 FDA-Required Warning For Singulair About Neuropsychiatric Events (Posted by Tom Lamb at DrugInjuryWatch.com) On June 12, 2009 the FDA announced a new warning about an increased risk of…
-
Smoking Cessation Drugs Chantix, Wellbutrin, And Zyban Are Getting New “Black-Box” Warning
Will Warn About Risk Of Serious Neuropsychiatric Symptoms Including Agitation, Depression, Suicidal Thoughts, And Attempted Suicide (Posted by Tom Lamb at DrugInjuryWatch.com) On July 1, 2009 the FDA issued a Public Health Advisory about…
-
Brandname Accutane Acne Medicine Is Being Removed From U.S. Market By Roche
Accutane Recall Due To Safety Issues Or Declining Sales Or Lawsuit Losses Or Some Combination Of These Factors? (Posted by Tom Lamb at DrugInjuryWatch.com)_____________________________________________________________________ Update: Accutane Retrial Verdict: Roche Ordered to Pay $25 Million to…
-
Generic Drug Maker Caraco Fails To Correct Manufacturing Problems First Discovered In May 2008
FDA And U.S. Marshals Seize Drug Products From Caraco’s Three Michigan Facilities Due To Continuing Lack Of Quality Controls (Posted by Tom Lamb at DrugInjuryWatch.com) On June 25, 2009 the FDA issued a press…